Blood test boosts lung cancer gene detection

NCT ID NCT04912687

Completed Diagnosis Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Mar 06, 2026 · Last updated Apr 30, 2026 · Updated 6 times

Summary

This study looked at whether adding a simple blood test (liquid biopsy) to the usual tissue biopsy can help find more EGFR gene mutations in people with advanced non-small cell lung cancer. Over 500 patients were tested using both methods. The goal was to see if the combination approach improves detection rates, which could help doctors choose better treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

CHRU Lille

Lille, 59037, France
CHU Nice-Hopital de Cimiel

Nice, 06000, France
CHU Poitiers

Poitiers, 86021, France
CHU Strasbourg

Strasbourg, 67091, France
CHU de Rennes - Hopital Pontchaillou

Rennes, 35033, France
Hospices Civils de Lyon

Lyon, 69002, France
Institut Bergonie

Bordeaux, 33076, France
Institut Curie

Paris, 75248, France
Institut de Cancérologie de l'Ouest - Site Paul Papin

Angers, 49000, France

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR NON SMALL CELL LUNG CANCER NON SMALL CELL LUNG CANCER